Loading treatment…
Prescription onlyCompounded — not FDA-approved
Tirzepatide
Prescription — weekly injection
A weekly injection that acts on two gut-hormone pathways rather than one, prescribed for medical weight loss when appropriate.
Compounded tirzepatide is not FDA-approved. FDA-approved tirzepatide products exist under brand names; a compounded copy is a different thing.
We don't offer this
We do not provide compounded tirzepatide, for the same reason as semaglutide: the shortage that permitted compounded copies ended in 2025, and a compounded copy of an available medication cannot lawfully be advertised. The FDA-approved branded products remain available through a provider.
See what we do offer for weight lossHow it works
What it actually does
Tirzepatide engages two receptors — GLP-1 and GIP — where semaglutide engages one. Both are hormones your gut releases in response to food, and both feed into appetite regulation and insulin response. Whether the dual mechanism is the right choice for you is a clinical judgement your provider makes; it is not automatically the better option.
See the full mechanism, step by stepThe evidence
What the trials actually found
Published results, with what they were measured against. A number without a comparator isn't evidence — it's advertising.
15.0% to 20.9% mean body-weight reduction
vs 3.1% on placebo
Over 72 weeks at 5mg to 15mg weekly in adults with obesity and without diabetes; the range reflects the dose.
Jastreboff et al., SURMOUNT-1 trial, New England Journal of Medicine, 2022
Trial averages describe a study population, not a prediction for you. Your provider will be direct about what is realistic given your history — and results depend on continuing treatment.
A provider may consider it if
- You and your provider have discussed both GLP-1 and dual-agonist options
- You're comfortable with a weekly injection and regular check-ins
It won't be prescribed if
- Anyone with a personal or family history of medullary thyroid carcinoma, or MEN 2 syndrome — a hard stop, as with all medications in this class
- Pregnancy, trying to become pregnant, or breastfeeding
- A history of pancreatitis, without careful provider review
- Type 1 diabetes, gastroparesis, or an active eating disorder without in-person care
These are the same checks the visit runs. If one applies, the visit will tell you plainly rather than take your money.
What to expect
Realistically, month by month
Weeks 1–4
A low starting dose while your gut adjusts. Side effects are most likely in the days after each step up.
Months 1–5
Gradual dose increases at your provider's direction, with tolerance assessed at every stage.
Ongoing
Reviewed at check-ins like any long-term treatment. There is no fixed finish line set in advance.
Safety, stated up front
Side effects, before you decide
Nausea, diarrhoea, vomiting, constipation and reduced appetite are common, typically clustering after dose increases. Serious but uncommon risks include pancreatitis, gallbladder disease and kidney injury from dehydration. Full information is provided before you're prescribed anything.
- FDA prescribing information: tirzepatide
- Boxed warning: thyroid C-cell tumour risk in rodents; same MTC and MEN 2 contraindications as other incretin therapies
Complete safety information is provided during your visit and with every prescription. This page is a summary, not a substitute for your provider's advice.
Questions
Asked honestly, answered honestly
Is tirzepatide better than semaglutide?
We won't answer that on a marketing page. They act on different numbers of pathways, they suit different people, and the comparison depends on your health history. That's a conversation with your provider.
Why is it priced higher?
It's a newer and generally more expensive medication. You'll see the full cost before you're charged anything, and the price is shown before the questionnaire, not after.
Also for weight loss
We don't prescribe this — but the conversation is still worth having
A provider can talk through what we do offer for weight loss, and be straight with you about what would actually help.